FTO attenuates TNF-α-induced damage of proximal tubular epithelial cells in acute pancreatitis-induced acute kidney injury via targeting AQP3 in an N6-methyladenosine-dependent manner

References

• Beyer G, Hoffmeister A, Lorenz P, et al. Clinical practice guideline—acute and chronic pancreatitis. Dtsch Arztebl Int. 2022;119:1–11.
   PubMedGoogle Scholar
• Nassar TI, Qunibi WY. AKI associated with acute pancreatitis. Clin J Am Soc Nephrol. 2019;14(7):1106–1115. doi: 10.2215/CJN.13191118.
   PubMed Web of Science ®Google Scholar
• Kellum JA, Romagnani P, Ashuntantang G, et al. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):52. doi: 10.1038/s41572-021-00284-z.
   PubMed Web of Science ®Google Scholar
• Wang Y, Liu K, Xie X, et al. Potential role of imaging for assessing acute pancreatitis-induced acute kidney injury. Br J Radiol. 2021;94(1118):20200802. doi: 10.1259/bjr.20200802.
   PubMed Web of Science ®Google Scholar
• Pickkers P, Darmon M, Hoste E, et al. Acute kidney injury in the critically ill: an updated review on pathophysiology and management. Intensive Care Med. 2021;47(8):835–850. doi: 10.1007/s00134-021-06454-7.
   PubMed Web of Science ®Google Scholar
• Ma D, Li C, Jiang P, et al. Inhibition of ferroptosis attenuates acute kidney injury in rats with severe acute pancreatitis. Dig Dis Sci. 2021;66(2):483–492. doi: 10.1007/s10620-020-06225-2.
   PubMed Web of Science ®Google Scholar
• Zhang XX, Wang HY, Yang XF, et al. Alleviation of acute pancreatitis-associated lung injury by inhibiting the p38 mitogen-activated protein kinase pathway in pulmonary microvascular endothelial cells. World J Gastroenterol. 2021;27(18):2141–2159. doi: 10.3748/wjg.v27.i18.2141.
   PubMed Web of Science ®Google Scholar
• Schönfeld P, Wieckowski MR, Lebiedzińska M, et al. Mitochondrial fatty acid oxidation and oxidative stress: lack of reverse electron transfer-associated production of reactive oxygen species. Biochim Biophys Acta. 2010;1797(6-7):929–938. doi: 10.1016/j.bbabio.2010.01.010.
   PubMed Web of Science ®Google Scholar
• Zhou D, Tan RJ, Fu H, et al. Wnt/β-catenin signaling in kidney injury and repair: a double-edged sword. Lab Invest. 2016;96(2):156–167. doi: 10.1038/labinvest.2015.153.
   PubMed Web of Science ®Google Scholar
• Chatterjee S, Sil PC. ROS-influenced regulatory cross-talk with wnt signaling pathway during perinatal development. Front Mol Biosci. 2022;9:889719. doi: 10.3389/fmolb.2022.889719.
   PubMed Web of Science ®Google Scholar
• Xie H, Jing Y, Xia J, et al. Aquaporin 3 protects against lumbar intervertebral disc degeneration via the wnt/β-catenin pathway. Int J Mol Med. 2016;37(3):859–864. doi: 10.3892/ijmm.2016.2470.
   PubMed Web of Science ®Google Scholar
• Xing L, Wen JG, Frøkiær J, et al. Ontogeny of the mammalian kidney: expression of aquaporins 1, 2, 3, and World J Pediatr. 2014;10(4):306–312. doi: 10.1007/s12519-014-0508-7.
   PubMed Web of Science ®Google Scholar
• Wang W, Geng X, Lei L, et al. Aquaporin-3 deficiency slows cyst enlargement in experimental mouse models of autosomal dominant polycystic kidney disease. Faseb J. 2019;33(5):6185–6196. doi: 10.1096/fj.201801338RRR.
   PubMed Web of Science ®Google Scholar
• Xie R, Wang J, Yao Y, et al. Fluid resuscitation via the rectum ameliorates hemodynamic disorders through adjusting aquaporin expression in an experimental severe acute pancreatitis model. Exp Ther Med. 2019;17(1):437–443. doi: 10.3892/etm.2018.6934.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yao H, Wang Q, et al. Aquaporin-3 attenuates oxidative stress-induced nucleus pulposus cell apoptosis through regulating the P38 MAPK pathway. Cell Physiol Biochem. 2018;50(5):1687–1697. doi: 10.1159/000494788.
   PubMedGoogle Scholar
• Kim NH, Kim HJ, Lee AY. Aquaporin-3 downregulation in vitiligo keratinocytes increases oxidative stress of melanocytes. Biomol Ther (Seoul). 2023;31(6):648–654. doi: 10.4062/biomolther.2023.112.
   PubMed Web of Science ®Google Scholar
• Ni L, Bai R, Zhou Q, et al. The correlation between ferroptosis and m6A methylation in patients with acute kidney injury. Kidney Blood Press Res. 2022;47(8):523–533. doi: 10.1159/000524900.
   PubMed Web of Science ®Google Scholar
• Ni WJ, Lu H, Ma NN, et al. RNA N(6) -methyladenosine modifications and potential targeted therapeutic strategies in kidney disease. Br J Pharmacol. 2023;180(1):5–24. doi: 10.1111/bph.15968.
   PubMed Web of Science ®Google Scholar
• Garbo S, Zwergel C, Battistelli C. m6A RNA methylation and beyond - the epigenetic machinery and potential treatment options. Drug Discov Today. 2021;26(11):2559–2574. doi: 10.1016/j.drudis.2021.06.004.
   PubMed Web of Science ®Google Scholar
• Jiang X, Liu B, Nie Z, et al. The role of m6A modification in the biological functions and diseases. Signal Transduct Target Ther. 2021;6:74.
   PubMed Web of Science ®Google Scholar
• You Y, Fu Y, Huang M, et al. Recent advances of m6A demethylases inhibitors and their biological functions in human diseases. Int J Mol Sci. 2022;23:5815.
   PubMed Web of Science ®Google Scholar
• Azzam SK, Alsafar H, Sajini AA. FTO m6A demethylase in obesity and cancer: implications and underlying molecular mechanisms. Int J Mol Sci. 2022;23:3800.
   PubMedGoogle Scholar
• Wu J, Yuan XH, Jiang W, et al. Genome-wide map of N(6)-methyladenosine circular RNAs identified in mice model of severe acute pancreatitis. World J Gastroenterol. 2021;27(43):7530–7545. doi: 10.3748/wjg.v27.i43.7530.
   PubMed Web of Science ®Google Scholar
• Zhou P, Wu M, Ye C, et al. Meclofenamic acid promotes cisplatin-induced acute kidney injury by inhibiting fat mass and obesity-associated protein-mediated m(6)a abrogation in RNA. J Biol Chem. 2019;294(45):16908–16917. doi: 10.1074/jbc.RA119.011009.
   PubMed Web of Science ®Google Scholar
• Xiao J, Chen W, Lu Y, et al. Crosstalk between peroxisome proliferator-activated receptor-γ and mineralcorticoid receptor in TNF-α activated renal tubular cell. Inflamm Res. 2015;64(8):603–614. doi: 10.1007/s00011-015-0838-5.
   PubMed Web of Science ®Google Scholar
• Yin X, Xue R, Wu J, et al. PINK1 ameliorates acute-on-chronic liver failure by inhibiting apoptosis through mTORC2/AKT signaling. Cell Death Discov. 2022;8(1):222. doi: 10.1038/s41420-022-01021-5.
   PubMed Web of Science ®Google Scholar
• Caslin HL, Taruselli MT, Haque T, et al. Inhibiting glycolysis and ATP production attenuates IL-33-mediated mast cell function and peritonitis. Front Immunol. 2018;9:3026. doi: 10.3389/fimmu.2018.03026.
   PubMed Web of Science ®Google Scholar
• Wang CY, Lin MH, Su HT. A method for measuring RNA N 6-methyladenosine modifications in cells and tissues. J Vis Exp. 2016;2016(118):54672.
   Web of Science ®Google Scholar
• Huang J, Sun W, Wang Z, et al. FTO suppresses glycolysis and growth of papillary thyroid cancer via decreasing stability of APOE mRNA in an N6-methyladenosine-dependent manner. J Exp Clin Cancer Res. 2022;41(1):42. doi: 10.1186/s13046-022-02254-z.
   PubMed Web of Science ®Google Scholar
• Xu Y, Zhou J, Li L, et al. FTO-mediated autophagy promotes progression of clear cell renal cell carcinoma via regulating SIK2 mRNA stability. Int J Biol Sci. 2022;18(15):5943–5962. doi: 10.7150/ijbs.77774.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408. doi: 10.1006/meth.2001.1262.
   PubMed Web of Science ®Google Scholar
• Sun L, Ling Y, Jiang J, et al. Differential mechanisms regarding triclosan vs. bisphenol a and fluorene-9-bisphenol induced zebrafish lipid-metabolism disorders by RNA-Seq. Chemosphere. 2020;251:126318. doi: 10.1016/j.chemosphere.2020.126318.
   PubMed Web of Science ®Google Scholar
• Zhang D, Wornow S, Peehl DM, et al. The controversial role and therapeutic development of the m6A demethylase FTO in renal cell carcinoma. Transl Oncol. 2022;25:101518. doi: 10.1016/j.tranon.2022.101518.
   PubMed Web of Science ®Google Scholar
• Yu Y, Pan Y, Fan Z, et al. LuHui derivative, a novel compound that inhibits the fat mass and obesity-associated (FTO), alleviates the inflammatory response and injury in hyperlipidemia-induced cardiomyopathy. Front Cell Dev Biol. 2021;9:731365. doi: 10.3389/fcell.2021.731365.
   PubMed Web of Science ®Google Scholar
• Ge MH, Tian H, Mao L, et al. Zinc attenuates ferroptosis and promotes functional recovery in contusion spinal cord injury by activating Nrf2/GPX4 defense pathway. CNS Neurosci Ther. 2021;27(9):1023–1040. doi: 10.1111/cns.13657.
   PubMed Web of Science ®Google Scholar
• He J, Yang B. Aquaporins in renal diseases. Int J Mol Sci. 2019;20:366.
   PubMed Web of Science ®Google Scholar
• Shi H, Wei J, He C. Where, when, and how: context-dependent functions of RNA methylation writers, readers, and erasers. Mol Cell. 2019;74(4):640–650. doi: 10.1016/j.molcel.2019.04.025.
   PubMed Web of Science ®Google Scholar
• Yang J, Zhang M, Yang D, et al. m(6)A-mediated upregulation of AC008 promotes osteoarthritis progression through the miR-328-3p–AQP1/ANKH axis. Exp Mol Med. 2021;53(11):1723–1734. doi: 10.1038/s12276-021-00696-7.
   PubMed Web of Science ®Google Scholar
• Zhang L, Wan Y, Zhang Z, et al. FTO demethylates m6A modifications in HOXB13 mRNA and promotes endometrial cancer metastasis by activating the WNT signalling pathway. RNA Biol. 2021;18(9):1265–1278. doi: 10.1080/15476286.2020.1841458.
   PubMed Web of Science ®Google Scholar
• Liu C, Liu L, Zhang Y, et al. Molecular mechanism of AQP3 in regulating differentiation and apoptosis of lung cancer stem cells through wnt/GSK-3β/β-catenin pathway. J Buon. 2020;25:1714–1720.
   PubMed Web of Science ®Google Scholar
• Song N, Cui K, Zhang K, et al. The role of m6A RNA methylation in cancer: implication for nature products anti-cancer research. Front Pharmacol. 2022;13:933332. doi: 10.3389/fphar.2022.933332.
   PubMed Web of Science ®Google Scholar
• Wang W, Li F, Sun Y, et al. Aquaporin-1 retards renal cyst development in polycystic kidney disease by inhibition of wnt signaling. Faseb J. 2015;29(4):1551–1563. doi: 10.1096/fj.14-260828.
   PubMed Web of Science ®Google Scholar
• Rim EY, Clevers H, Nusse R. The wnt pathway: from signaling mechanisms to synthetic modulators. Annu Rev Biochem. 2022;91(1):571–598. doi: 10.1146/annurev-biochem-040320-103615.
   PubMedGoogle Scholar
• Meng P, Zhu M, Ling X, et al. Wnt signaling in kidney: the initiator or terminator? J Mol Med (Berl). 2020;98(11):1511–1523. doi: 10.1007/s00109-020-01978-9.
   PubMed Web of Science ®Google Scholar
• Schunk SJ, Floege J, Fliser D, et al. WNT-β-catenin signalling - a versatile player in kidney injury and repair. Nat Rev Nephrol. 2021;17(3):172–184. doi: 10.1038/s41581-020-00343-w.
   PubMed Web of Science ®Google Scholar
• Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell. 2012;149(6):1192–1205. doi: 10.1016/j.cell.2012.05.012.
   PubMed Web of Science ®Google Scholar